Plastic surgeons conducted 17.9 million surgical operations and 17.3 million non-surgical treatments throughout the past year. Eyelid surgery leads the surgical category with 2.4 million procedures, followed by liposuction, breast augmentation, breast lift, and abdominoplasty. Among non-surgical options, botulinum toxin accounted for 7.3 million procedures, significantly outpacing the 4.7 million hyaluronic acid filler treatments performed worldwide.
In section Releases
Global Plastic Surgery Trends: Eyelid Procedures Top 2026 Rankings
With over 35 million aesthetic procedures performed globally in 2025, the International Society of Aesthetic Plastic Surgery reports a 9.2% increase in demand over the last four years. Eyelid surgery currently holds the top spot for surgical interventions, while botulinum toxin remains the dominant non-surgical choice.
Data from 51 markets reveals notable shifts in patient demographics and preferences. Breast lift surgeries surged by 48%, marking the highest percentage growth, while hyaluronic acid injectables saw a 25% decline. The United States remains the global leader in total volume with 5.4 million procedures, followed by Brazil, which leads specifically in surgical volume, and China. While women continue to represent over 84% of the total patient base, specific trends emerge by age: younger patients aged 18–34 primarily drive breast augmentations and rhinoplasties, whereas those aged 35–50 favor liposuction and injectable treatments.
Comments (0)
No comments yet. Be the first!